Skip to main content

Advertisement

SpringerLink
Log in

Hypoxia-Inducible Factor 1-Alpha Release After Intracoronary Versus Intramyocardial Stem Cell Therapy in Myocardial Infarction

  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

Abstract

We have investigated the effect of stem cell delivery on the release of hypoxia-inducible factor 1 alpha (HIF-1α) in peripheral circulation and myocardium in experimental myocardial ischemia. Closed-chest, reperfused myocardial infarction (MI) was created in domestic pigs. Porcine mesenchymal stem cells (MSCs) were cultured and delivered (9.8 ± 1.2 × 106) either percutaneously NOGA-guided transendocardially (Group IM) or intracoronary (Group IC) 22 ± 4 days post-MI. Pigs without MSC delivery served as sham control (Group S). Plasma HIF-1α was measured at baseline, immediately post- and at follow-up (FUP; 2 h or 24 h) post-MSC delivery by ELISA kit. Myocardial HIF-1α expression of infarcted, normal myocardium, or border zone was determined by Western blot. Plasma level of HIF-1α increased immediately post-MI (from 278 ± 127 to 631 ± 375 pg/ml, p < 0.05). Cardiac delivery of MSCs elevated the plasma levels of HIF-1α significantly (p < 0.05) in groups IC and IM immediately post-MSC delivery, and returned to baseline level at FUP, without difference between the groups IC and IM. The myocardial tissue HIF-1α expression in the infarcted area was higher in Group IM than in Group IC or S (1,963 ± 586 vs. 1,307 ± 392 vs. 271 ± 110 activity per square millimeter, respectively, p < 0.05), while the border zone contained similarly lower level of HIF-1α, but still significantly higher as compared with Group S. Trend towards increase in myocardial expression of HIF-1α was measured in Group IM at 24 h, in contrast to Group IC. In conclusion, both stem cell delivery modes increase the systemic and myocardial level of HIF-1α. Intramyocardial delivery of MSC seems to trigger the release of angiogenic HIF-1α more effectively than does intracoronary delivery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Assmus, B., Schachinger, V., Teupe, C., et al. (2002). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation, 106, 3009–3017.

    Article  PubMed  Google Scholar 

  2. Janssens, S., Theunissen, K., Boogaerts, M., & Van de Werf, F. (2006). Bone marrow cell transfer in acute myocardial infarction. Nat Clin Pract Cardiovasc Med, 3(Suppl 1), S69–S72.

    Article  PubMed  Google Scholar 

  3. Lunde, K., Solheim, S., Aakhus, S., et al. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. New England Journal of Medicine, 355, 1199–1209.

    Article  CAS  PubMed  Google Scholar 

  4. Bartunek, J., Croissant, J. D., Wijns, W., et al. (2007). Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factor and repair of the chronically infarcted myocardium. American Journal of Physiology. Heart and Circulatory Physiology, 292, H1095–H1104.

    Article  CAS  PubMed  Google Scholar 

  5. Charwat, S., Gyöngyösi, M., Lang, I., et al. (2008). Role of adult bone marrow stem cells in the repair of ischemic myocardium, current state of the art. Experimental Hematology, 36, 672–680.

    Article  CAS  PubMed  Google Scholar 

  6. Gyöngyösi, M., Lang, I., Dettke, M., et al. (2009). Comparison of early and late combined cardiac application of bone marrow mononuclear stem cells after myocardial infarction. Final results from the MYSTAR prospective randomized study. Nat Clin Pract Cardiovasc Med, 6, 70–81.

    Article  PubMed  Google Scholar 

  7. Orlic, D., Kajstura, J., Chimenti, S., et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410, 701–705.

    Article  CAS  PubMed  Google Scholar 

  8. Kocher, A. A., Schuster, M. D., Szabolcs, M. J., et al. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Medicine, 7, 430–436.

    Article  CAS  PubMed  Google Scholar 

  9. Gyöngyösi, M., Blanco, J., Marian, T., et al. (2008). Serial non-invasive in vivo positron emmission tomographyc (PET) tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circulation Cardiovascular Imaging, 1, 94–103.

    Article  PubMed  Google Scholar 

  10. Strauer, B., Brehm, M., Zeus, T., et al. (2002). Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation, 106, 1913–1918.

    Article  PubMed  Google Scholar 

  11. Schachinger, V., Erbs, S., Elsasser, A., et al. (2006). Intracoronary bone marrow derived progenitor cells in acute myocardial infarction. New England Journal of Medicine, 355, 1210–1221.

    Article  CAS  PubMed  Google Scholar 

  12. Orlic, D., Kajstura, J., Chimenti, S., et al. (2001). Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proceedings of the National Academy of Sciences of the United States of America, 98, 10344–10349.

    Article  CAS  PubMed  Google Scholar 

  13. Dimmeler, J., Zeiher, A., & Schneider, M. D. (2005). Unchain my heart, the scientific foundations of cardiac repair. Journal of Clinical Investigation, 115, 572–583.

    CAS  PubMed  Google Scholar 

  14. Wang, G. L. & Semenza, G. L. (1993). General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proceedings of the National Academy of Sciences of the United States of America, 90, 4304–4308.

    Article  CAS  PubMed  Google Scholar 

  15. Wenger, R. H. (2002). Cellular adaptation to hypoxia, O2 sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2 regulated gene expression. FASEB Journal, 16, 1151–1162.

    Article  CAS  PubMed  Google Scholar 

  16. Chan, D. A. & Giaccia, A. J. (2007). Hypoxia, gene expression, and metastasis. Cancer and Metastasis Reviews, 26, 333–339.

    Article  CAS  PubMed  Google Scholar 

  17. Vincent, K. A., Shyu, K. G., Luo, Y., et al. (2000). Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DANN encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation, 102, 2255–2261.

    CAS  PubMed  Google Scholar 

  18. Wiener, C. M., Booth, G., & Semenza, G. L. (1996). In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochemical and Biophysical Research Communications, 225, 485–488.

    Article  CAS  PubMed  Google Scholar 

  19. Jiang, B., Rue, E., Wang, G. L., Roe, R., & Semenza, G. L. (1996). Dimerization, DANN binding, and transactivation properties of hypoxia-inducible factor 1. Journal of Biological Chemistry, 271, 17771–17778.

    Article  CAS  PubMed  Google Scholar 

  20. Jewell, U. R., Kvietikova, I., Scheid, A., et al. (2001). Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB Journal, 15, 1312–1314.

    CAS  PubMed  Google Scholar 

  21. Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998). Regulation of hypoxia-inducible factor 1 is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proceedings of the National Academy of Sciences of the United States of America, 95, 7987–7992.

    Article  CAS  PubMed  Google Scholar 

  22. Kallio, P. J., Wilson, W. J., O’Brien, S., Makino, Y., & Poellinger, L. (1999). Regulation of the hypoxia-inducible transcription factor 1 by the ubiquitin-proteasome pathway. Journal of Biological Chemistry, 274, 6519–6525.

    Article  CAS  PubMed  Google Scholar 

  23. Salceda, S. & Caro, J. (1997). Hypoxia-inducible factor 1 (HIF-1) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. Journal of Biological Chemistry, 272, 22642–22647.

    Article  CAS  PubMed  Google Scholar 

  24. Huang, M., Chan, D. A., Jia, F., et al. (2008). Short hairpin RNA interference therapy for ischemic heart disease. Circulation, 118, S226–S233.

    Article  CAS  PubMed  Google Scholar 

  25. Dekel, B., Shezen, E., Even-Tov-Friedman, S., et al. (2006). Transplantation of human hematopoietic stem cells into ischemic and growing kidneys suggests a role in vasculogenesis but not tubulogenesis. Stem Cells, 24, 1185–1193.

    Article  CAS  PubMed  Google Scholar 

  26. Azarnoush, K., Maurel, A., Sebbah, L., et al. (2005). Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1alpha. Journal of Thoracic and Cardiovascular Surgery, 130(1), 173–179.

    Article  CAS  PubMed  Google Scholar 

  27. Rhoads, R. P., Johnson, R. M., Rathbone, C. R., et al. (2009). Satellite cell-mediated angiogenesis in vitro coincides with a functional hypoxia-inducible factor pathway. American Journal of Physiology. Cell Physiology, 296(6), C1321–C1328.

    Article  CAS  PubMed  Google Scholar 

  28. Ben-Haim, S. A., Osadchy, D., Schuster, I., et al. (1996). Nonfluoroscopic, in vivo navigation and mapping technology. Nature Medicine, 2, 1393–1395.

    Article  CAS  PubMed  Google Scholar 

  29. Gepstein, L., Hayam, G., & Ben-Haim, S. A. (1997). A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart, in vitro and in vivo accuracy results. Circulation, 95, 1611–1622.

    CAS  PubMed  Google Scholar 

  30. Gyöngyösi, M., Sochor, H., Khorsand, A., Gepstein, L., & Glogar, D. (2001). Online myocardial viability assessment in the catheterization laboratory via NOGA electroanatomic mapping. Quantitative comparison with thallium-201 uptake. Circulation, 104, 1005–1011.

    Article  PubMed  Google Scholar 

  31. Kastrup, J., Jørgensen, E., Rück, A., et al. (2005). Direct intramyocardial plasmid VEGF-A165 gene therapy in patients with stable severe angina pectoris—A randomized double-blind placebo-controlled study—The Euroinject One Trial. Journal of the American College of Cardiology, 45, 982–988.

    Article  CAS  PubMed  Google Scholar 

  32. Ockaili, R., Natarajan, R., Salloum, F., et al. (2005). HIF-1 activation attenuates post-ischemic myocardial injury, a role for heme oxygenase-1 in modulating microvascular chemokine generation. American Journal of Physiology. Heart and Circulatory Physiology, 289, H542–H548.

    Article  CAS  PubMed  Google Scholar 

  33. Xi, L., Taher, M., Yin, C., Salloum, F., & Kukreja, R. C. (2004). Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1alpha and AP-1 and iNOS signaling. American Journal of Physiology. Heart and Circulatory Physiology, 287, H2369–H2375.

    Article  CAS  PubMed  Google Scholar 

  34. Martin, C., Yu, A. Y., Jiang, B. H., et al. (1998). Cardiac hypertrophy in chronically anemic fetal sheep, increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. American Journal of Obstetrics and Gynecology, 178, 527–534.

    Article  CAS  PubMed  Google Scholar 

  35. Bilton, R. L. & Booker, G. W. (2003). The subtle side to hypoxia inducible factor (HIFalpha) regulation. European Journal of Biochemistry, 270, 791–798.

    Article  CAS  PubMed  Google Scholar 

  36. Liu, Y., Cox, S. R., Morita, T., & Kourembanas, S. (1995). Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5= enhancer. Circulation Research, 77, 638–643.

    CAS  PubMed  Google Scholar 

  37. Kim, C. H., Cho, Y. S., Chun, Y. S., et al. (2002). Early expression of myocardial HIF-1alpha in response to mechanical stresses, regulation by stretch-activated channels and the phosphatidylinositol-3-kinase signaling pathway. Circulation Research, 90, E25–E33.

    Article  CAS  PubMed  Google Scholar 

  38. Wang, C., Weihrauch, D., Schwabe, D. A., et al. (2006). Extracellular signal-regulated kinases trigger isoflurane preconditioning concomitant with upregulation of hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in rats. Anesthesia and Analgesia, 103, 281–288.

    Article  CAS  PubMed  Google Scholar 

  39. Lee, S. H., Wolf, P. L., Escudero, R., et al. (2000). Early expression of angiogenesis factors in acute myocardial ischemia and infarction. New England Journal of Medicine, 342, 626–633.

    Article  CAS  PubMed  Google Scholar 

  40. Pugh, C. W. & Ratcliffe, P. J. (2003). Regulation of angiogenesis by hypoxia, role of the HIF system. Nature Medicine, 9, 677–684.

    Article  CAS  PubMed  Google Scholar 

  41. Chang, E. I., Loh, S. A., Ceradini, D. J., et al. (2007). Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1alpha stabilization during ischemia. Circulation, 116, 2818–2829.

    Article  CAS  PubMed  Google Scholar 

  42. Loor, G. & Schumacker, P. T. (2008). Role of hypoxia-inducible factor in cell survival during myocardial ischemia–reperfusion. Cell Death and Differentiation, 15, 686–690.

    Article  CAS  PubMed  Google Scholar 

  43. Wang, L. & ChunHua, R. (2009). Mesenchymal stem cells targeting the GVHD. Science in China. Series C, Chemistry, Life Sciences, 52, 603–609.

    Article  Google Scholar 

  44. Aggarwal, S. & Pittenger, M. F. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105, 1815–1822.

    Article  CAS  PubMed  Google Scholar 

  45. Schmid-Brunclik, N., Bürgi-TaboaAntoniou, X., Gassman, M., & Ogunshola, O. O. (2008). Astrocyte responses to injury: VEGF simultaneously modulates cell death and proliferation. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 295, R864–R873.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgement

This study was supported by the Ludwig Boltzmann Institute Cluster for Cardiovascular Research and Grant 41-069/2007—Lascor, funded by the Romanian Ministry of Research.

Author information

Authors and Affiliations

  1. Department of Cardiology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria

    Mariann Gyöngyösi, Rayyan Hemetsberger, Aniko Posa, Silvia Charwat, Noemi Pavo, Imre J. Pavo, Hani Hemetsberger, Christoph Kaun & Gerald Maurer

  2. Institute of Diagnostic Imaging and Radiation Oncology, University of Kaposvar, 7400, Kaposvár, Guba S. 40, Hungary

    Örs Petnehazy & Zsolt Petrasi

  3. University of Targu Mures, Str. Gh. Marinescu nr. 50, Târgu-Mureş, Romania

    Imre Benedek, Teodora Benedek, Istvan Benedek Jr & Istvan Kovacs

Authors
  1. Mariann Gyöngyösi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rayyan Hemetsberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aniko Posa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Silvia Charwat
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Noemi Pavo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Örs Petnehazy
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zsolt Petrasi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Imre J. Pavo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hani Hemetsberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Imre Benedek
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Teodora Benedek
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Istvan Benedek Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Istvan Kovacs
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Christoph Kaun
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Gerald Maurer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mariann Gyöngyösi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gyöngyösi, M., Hemetsberger, R., Posa, A. et al. Hypoxia-Inducible Factor 1-Alpha Release After Intracoronary Versus Intramyocardial Stem Cell Therapy in Myocardial Infarction. J. of Cardiovasc. Trans. Res. 3, 114–121 (2010). https://doi.org/10.1007/s12265-009-9154-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12265-009-9154-1

Keywords

Search

Navigation